Aldeyra Therapeutics Inc
ALDX5.080USD
+0.270+5.61%
收盤 08/04, 16:00（美東）報價延遲15分鐘
305.03M總市值
虧損本益比TTM
關於 Aldeyra Therapeutics Inc 公司
Aldeyra Therapeutics, Inc. 是一家生物技術公司，致力於發現用於治療免疫介導疾病的療法。該公司的候選產品包括活性醛 (RASP) 調節劑 ADX-629、ADX-246、ADX-248 和用於治療全身和視網膜免疫介導疾病的化學相關分子。其商業化前候選產品是 reproxalap，一種用於治療乾眼症和過敏性結膜炎的 RASP 調節劑，以及 ADX-2191，一種用於治療增生性玻璃體視網膜病變和視網膜色素變性的新型玻璃體內甲氨蝶呤製劑。其 ADX-629 是一種口服 RASP 調節劑，目前正在臨牀開發中，用於治療特應性皮炎、特發性腎病綜合徵、中度酒精相關性肝炎、慢性咳嗽和 Sjogren-Larsson 綜合徵。其臨牀前 RASP 平臺包括正在開發用於治療代謝、視網膜疾病和全身炎症疾病的 ADX-246 和 ADX-248。
公司簡介
公司代碼ALDX
公司名稱Aldeyra Therapeutics Inc
上市日期May 02, 2014
CEODr. Todd C. Brady, M.D., Ph.D.
員工數量9
證券類型Ordinary Share
年結日May 02
公司地址131 Hartwell Avenue
城市LEXINGTON
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編02421
電話17817614904
網址https://www.aldeyra.com/
公司代碼ALDX
上市日期May 02, 2014
CEODr. Todd C. Brady, M.D., Ph.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Todd C. Brady, M.D., Ph.D.
Dr. Todd C. Brady, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.42M
+23.16%
Dr. Richard H. Douglas, Ph.D.
Dr. Richard H. Douglas, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
125.00K
--
Mr. Martin J. Joyce
Mr. Martin J. Joyce
Independent Director
Independent Director
23.97K
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Director
Independent Director
14.81K
--
Dr. Neal S. Walker
Dr. Neal S. Walker
Independent Director
Independent Director
--
--
Dr. Stephen G. Machatha, Ph.D.
Dr. Stephen G. Machatha, Ph.D.
Chief Development Officer
Chief Development Officer
--
--
Dr. Ben R. Bronstein, M.D.
Dr. Ben R. Bronstein, M.D.
Independent Director
Independent Director
--
--
Ms. Nancy B. Miller-Rich
Ms. Nancy B. Miller-Rich
Independent Director
Independent Director
--
--
Mr. William (Chip) Clark
Mr. William (Chip) Clark
Independent Director
Independent Director
--
--
Mr. Michael (Mike) Alfieri
Mr. Michael (Mike) Alfieri
Principal Financial Officer and Principal Accounting Officer
Principal Financial Officer and Principal Accounting Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Todd C. Brady, M.D., Ph.D.
Dr. Todd C. Brady, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.42M
+23.16%
Dr. Richard H. Douglas, Ph.D.
Dr. Richard H. Douglas, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
125.00K
--
Mr. Martin J. Joyce
Mr. Martin J. Joyce
Independent Director
Independent Director
23.97K
--
Dr. Gary M. Phillips, M.D.
Dr. Gary M. Phillips, M.D.
Independent Director
Independent Director
14.81K
--
Dr. Neal S. Walker
Dr. Neal S. Walker
Independent Director
Independent Director
--
--
Dr. Stephen G. Machatha, Ph.D.
Dr. Stephen G. Machatha, Ph.D.
Chief Development Officer
Chief Development Officer
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Knoll Capital Management, LLC
9.14%
Perceptive Advisors LLC
8.14%
The Vanguard Group, Inc.
6.21%
BlackRock Institutional Trust Company, N.A.
5.70%
Ardsley Advisory Partners LP
2.92%
Other
67.89%
持股股東
持股股東
佔比
Knoll Capital Management, LLC
9.14%
Perceptive Advisors LLC
8.14%
The Vanguard Group, Inc.
6.21%
BlackRock Institutional Trust Company, N.A.
5.70%
Ardsley Advisory Partners LP
2.92%
Other
67.89%
股東類型
持股股東
佔比
Investment Advisor
19.59%
Hedge Fund
16.52%
Investment Advisor/Hedge Fund
9.81%
Private Equity
8.14%
Individual Investor
3.13%
Research Firm
2.42%
Pension Fund
0.17%
Bank and Trust
0.10%
Family Office
0.08%
Other
40.04%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
293
35.88M
59.90%
-7.96M
2025Q1
315
40.31M
67.37%
-4.94M
2024Q4
306
39.84M
66.72%
-5.42M
2024Q3
295
38.52M
64.82%
-5.60M
2024Q2
290
37.23M
62.65%
-8.21M
2024Q1
294
37.04M
62.88%
-7.70M
2023Q4
296
36.84M
62.63%
-6.52M
2023Q3
298
39.89M
68.07%
-12.41M
2023Q2
305
41.03M
70.05%
-8.66M
2023Q1
311
38.11M
64.83%
-12.64M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Knoll Capital Management, LLC
5.48M
9.14%
--
--
Mar 31, 2025
Perceptive Advisors LLC
4.88M
8.14%
-4.40M
-47.44%
Apr 03, 2025
The Vanguard Group, Inc.
3.72M
6.21%
-38.77K
-1.03%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.41M
5.7%
-50.91K
-1.47%
Mar 31, 2025
Ardsley Advisory Partners LP
1.75M
2.92%
+600.00K
+52.17%
Mar 31, 2025
Brady (Todd C)
1.42M
2.38%
+267.69K
+23.16%
Apr 14, 2025
Kennedy Capital Management LLC
1.23M
2.06%
-235.10K
-16.01%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.14M
1.9%
+18.27K
+1.63%
Mar 31, 2025
State Street Global Advisors (US)
1.02M
1.71%
-11.99K
-1.16%
Mar 31, 2025
Kingdon Capital Management, L.L.C.
779.00K
1.3%
+779.00K
--
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.8%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
Vanguard US Momentum Factor ETF
0.02%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.8%
iShares Micro-Cap ETF
佔比0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.02%
Vanguard US Momentum Factor ETF
佔比0.02%
Global X Russell 2000 ETF
佔比0.01%
Proshares Ultra Russell 2000
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
iShares Russell 2000 Growth ETF
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
